Zevra Therapeutics Vs. Xeris Biopharma Holdings Industry Stock Comparison

Buy

67

ZVRA
Zevra Therapeutics

Last Price:

9.53

Seasonality Move:

6.65%

Buy

83

XERS
Xeris Biopharma Holdings

Last Price:

3.08

Seasonality Move:

-0.27%

Buy

67

Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics a Buy, Sell or Hold?

The current Zevra Therapeutics [ZVRA] share price is $9.13. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

83

Xeris Biopharma Holdings (XERS) is a Buy

Is Xeris Biopharma Holdings a Buy, Sell or Hold?

The current Xeris Biopharma Holdings [XERS] share price is $3.04. The Score for XERS is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

ZVRA Stock Price Chart

What is Zevra Therapeutics's stock price today?

The Zevra Therapeutics share price today is $9.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.

XERS Stock Price Chart

What is Xeris Biopharma Holdings's stock price today?

The Xeris Biopharma Holdings share price today is $3.04
The current trend is relatively stagnant and XERS is experiencing selling pressure, which indicates risk of future bearish movement.

ZVRA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.24	Buy
Relative Strength Index (14 RSI):	61.61	Buy
Chaikin Money Flow:	68733	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.17 - 8.91)	Buy
Bollinger Bands (100):	(6.37 - 8.45)	Buy

XERS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	46.54	Sell
Chaikin Money Flow:	-1008304	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.02 - 3.3)	Sell
Bollinger Bands (100):	(2.44 - 3.1)	Buy

ZVRA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.82	Buy
20-day SMA:	8.62	Buy
50-day SMA:	8.15	Buy
200-day SMA:	6.34	Buy
8-day EMA:	8.88	Buy
20-day EMA:	8.66	Buy
50-day EMA:	8.18	Buy
200-day EMA:	6.74	Buy

XERS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.04	Buy
20-day SMA:	3.18	Sell
50-day SMA:	3.03	Buy
200-day SMA:	2.5	Buy
8-day EMA:	3.06	Sell
20-day EMA:	3.11	Sell
50-day EMA:	3.01	Buy
200-day EMA:	2.6	Buy

Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.

Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.

Zevra Therapeutics Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Xeris Biopharma Holdings Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):